GlassScriptPhysician profile
Sean M Fahey
NPI 1619976479
$3,552.67
in general payments reported to CMS, 2019-2025
10 companies · $67.79 in 2025
The $67.79 reported for 2025 was less than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,964 · 2021: $17.01 · 2022: $234 · 2023: $144 · 2024: $126 · 2025: $67.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $265 · Education: $72.45.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $265.31 |
| Education | $72.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cardinal Health 108 LLC | $2,944.64 | 2019 | |
| Amgen INC. | $126.42 | 2021-2023 | Tavneos |
| Genzyme Corporation | $102.00 | 2022 | |
| Aurinia Pharma U.S., INC. | $95.26 | 2022 | |
| Janssen Biotech, INC. | $83.02 | 2022-2025 | Tremfya |
| Novartis Pharmaceuticals Corporation | $80.38 | 2024-2025 | |
| Radius Health, INC. | $73.13 | 2023-2024 | Tymlos |
| Pacira Therapeutics, INC. | $19.61 | 2019 | |
| Genentech USA, INC. | $14.16 | 2025 | Actemra |
| Abbvie INC. | $14.05 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sean Fahey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.